What is the total value and per-share offer price of CVC and GBL's takeover bid for Recordati, and what premium does it represent?

CVC Capital Partners and GBL launched a €10.7 billion full voluntary cash bid for Recordati, offering €51.29 per share ex dividend, which incorporates a 12.89% premium compared to Recordati's share price on March 25—the day before Recordati announced CVC's non-binding expression of interest.

Who are the key parties involved in the bid, and what is the stated strategic commitment of CVC and GBL toward Recordati?

The bid is led by private equity firm CVC Capital Partners (CVC.AS) and Belgian investment group GBL (GBLB.BR), acting through a newly formed Italian joint stock company; they describe themselves as 'co-control investors' with a 'clear commitment to support the Company’s development over the long term', backed by a 'committed, flexible and stable shareholder base'. Additionally, Recordati's controlling shareholder Rossini has agreed to tender its entire 46.82% stake.

CVC, GBL Launch 10.7 Billion Euro Takeover Offer for Italy's Recordati

May 21, 2026

Private equity firms CVC and GBL launched a €10.7 billion cash bid to take over Italian pharmaceutical group Recordati, offering €51.29 per share. The controlling shareholder has agreed to tender its 46.82% stake as part of the deal aimed at delisting the company.

reuters

2026-05-21

CVC, GBL Launch 10.7 Billion Euro Takeover Offer for Italy's Recordati

2026-07-15

Italy's Recordati says board finds CVC, GBL offer 'fair' as independent directors dissent

CVC, GBL Launch 10.7 Billion Euro Takeover Offer for Italy's Recordati

FAQ